PEDIATRICS Vol. 33 No. 1 January 1964, pp. 123-134
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kleinman, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleinman, D. S.

PHENYLKETONURIA

A Review of Some Deficits in Our Information

David S. Kleinman 1

1 Bureau of Maternal and Child Health, California State Department of Public Health, Berkeley, California

The dietary regimen is a difficult one; it must be closely controlled by the physician if complications are to be avoided. Although effective in limiting pathology, if administered early and maintained, evidence is not yet presented as to whether it is fully protective.

Estimates of the incidence and prevalence of phenylketonuria are not well established. There are indications that, although rare, the incidence may be considerably higher than the 1 in 20,000 to 25,000 births previously estimated. Discrepancies in the estimates should be explored for possible explanation. These may relate to different population frequencies, definitions of mental retardation, and screening and testing procedures.

The degree of variability in the manifestations (or expressivity) of phenylketonuria in mental retardation and other effects has not been adequately examined. Investigation of the factors relating to this variability may provide information regarding the mechanics of pathology and lead to improved screening and therapeutic measures.

Submitted on June 7, 1963
Accepted on August 15, 1963